BOSTON, Feb. 26 /PRNewswire-FirstCall/ -- AMICAS, Inc. , a leader in radiology and medical image and information management solutions, today announced that it has executed a distribution agreement with NeuroLogica, a neuroscience-based medical imaging company. The agreement makes AMICAS' industry acclaimed software available in NeuroLogica's CereTom(TM), the world's first portable and wireless head and neck mobile CT.
(Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO )
The CereTom portable CT scanner is a compact, lightweight, portable, high speed, battery, and line powered multi-slice CT scanner optimized for scanning anatomy such as the head and neck. Designed to make CT scans accessible beyond the large scanners in the radiology department, the CereTom is compact enough to be used in intensive care units, operating rooms, emergency departments, clinics, and locations outside of a healthcare facility.
It is our belief that physicians using the CereTom portable CT scanner bundled with AMICAS' image management software will be able to provide their patients with a more timely diagnosis as a result of the high quality images delivered directly from the scanner to a Web browser. This bundled solution will allow specialty physicians, such as neurologists and ear, nose, and throat specialists, to provide first-class care to their patients in an outpatient setting.
"Our partnership with AMICAS provides two particularly valuable benefits to our customers. The first is access to unprecedented image quality delivered directly from the scanner to a Web browser. The second is access to AMICAS' end-to-end suite of image and information management solutions for those practices seeking such capabilities," said Eric Bailey, president and chief operating officer of NeuroLogica Corporation.
"NeuroLogica has wisely chosen to add AMICAS' Web-based image platform to its CereTom as a means to differentiate their solution. AMICAS is able to expand distribution of its image management technology and end-to-end product suite. As partners, we are able to provide the entire imaging IT experience - - from scheduling and image production to interpretation and revenue cycle management," said Barry Gutwillig, vice president of strategic initiatives and partnerships at AMICAS, Inc.
AMICAS' powerful end-to-end solutions empower outpatient facilities with PACS, RIS, enterprise document management, and revenue cycle management tools. AMICAS, in the business of developing, deploying, and supporting software solutions for over thirty years, is in a unique position to capitalize on the distribution opportunities afforded by this partnership.
AMICAS, Vision Series and AMICAS Insight are trademarks or registered trademarks of AMICAS, Inc. All other company and trademark names are the property of their respective owners.
About AMICAS, Inc.
AMICAS, Inc. (www.amicas.com) is a leader in radiology and medical image and information management solutions. The AMICAS(R) Vision Series(TM) products provide a complete, end-to-end solution for imaging centers, ambulatory care facilities, and radiology practices. Acute care and hospital clients are provided a fully-integrated, HIS/RIS-independent PACS, featuring advanced enterprise workflow support and scalable design. Complementing the Vision Series product family is AMICAS Insight(TM) Solutions, a set of client- centered professional and consulting services that assist our customers with a well-planned transition to a digital enterprise.
About NeuroLogica
Based in Danvers, MA, NeuroLogica Corporation, a neuroscience-based imaging company, develops, manufactures, and markets advanced medical imaging equipment. The company's mission is to bring access to high quality medical imaging to all people regardless of where they live. Combining this imaging quality and access enables physicians to make more informed treatment decisions, especially in stroke emergencies, saving and improving patient lives.
Safe Harbor Statement
Except for the historical information herein, the matters discussed in this release and to be discussed in the presentation may include forward- looking statements. These forward-looking statements include statements about future financial and operating results. When used in this press release and in the presentation, the words: believes, intends, plans, anticipates, expects, estimates, and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are subject to a number of risks, assumptions, and uncertainties that could cause actual results to differ materially which include the risks set forth in AMICAS' most recent filings with the Securities and Exchange Commission. All forward-looking statements in this release, any links herein and in the Company's presentation are qualified by these cautionary statements and are made only as of the date made. AMICAS is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.
AMICAS CONTACT: NEUROLOGICA CONTACT: Aine Cryts Tom Bain Marketing Communications Manager Account Director, Racepoint Group 617.779.7802 781.487.4616 acryts@amicas.comtbain@racepointgroup.com
Photo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comAMICAS, Inc.CONTACT: Aine Cryts, Marketing Communications Manager of AMICAS, Inc.,+1-617-779-7802, or acryts@amicas.com; or Tom Bain, Account Director,Racepoint Group, 1-781-487-4616, or tbain@racepointgroup.com, forNeuroLogica
Web site: http://www.amicas.com/
